Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lyri Adar"'
Autor:
Shira Peleg Hasson, Dov Hershkovitz, Lyri Adar, Miriam Brezis, Eliya Shachar, Rona Aks, Lee Galmor, Yuval Raviv, Shira Ben Neriah, Ofer Merimsky, Edmond Sabo, Ido Wolf, Tamar Safra
Publikováno v:
Cancers; Volume 15; Issue 1; Pages: 218
Comprehensive genomic profiling (CGP) allows for the detection of driver alterations at high resolution, but the limited number of approved targeted therapies and their high costs have contributed to its limited clinical utilization. We retrospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a4017eea9a8d562a39f2fc3ca33aca6
Autor:
Miriam Brezis, Shira Peleg Hasson, Eliya Shachar, Dan Grisaro, Ido Laskov, Nadav Michaan, Lyri Adar, Avigail Harpaz, Adi Diner, Bar Levy, Ido Wolf, Tamar Safra
Publikováno v:
E-Posters.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3c7f7daa12be881f08e1569f2f8eb85
https://doi.org/10.1136/ijgc-2022-igcs.298
https://doi.org/10.1136/ijgc-2022-igcs.298
Autor:
Miriam Rivka Brezis, Shira Peleg Hasson, Eliya Shachar, Dan Grisaro, Ido Laskov, Nadav Michaan, Lyri Adar, Avigail Harpaz, Adi Diner, Bar Levy, Ido Wolf, Tamar Safra
Publikováno v:
Ovarian cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a8f6e1d053beb3722f8e16573d6492d
https://doi.org/10.1136/ijgc-2022-esgo.483
https://doi.org/10.1136/ijgc-2022-esgo.483
Brain metastasis (BM) are uncommon among women with epithelial ovarian cancer (EOC). The frequency, risk factors and clinical repercussions of BM in these patients are not well described. We retrospectively evaluated EOC patients treated at our cente
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b28b34496f5b241f1d5515cf2ca382b8
Publikováno v:
Neuro-oncology Advances
Background Brain metastasis (BM) are uncommon among ovarian cancer (OC) patients. Their frequency, risk factors and clinical repercussions are not well described. We assessed OC patients who developed BM, the role of BRCA status and survival implicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d182265dc50fa2adbf349c65c139dd5
http://europepmc.org/articles/PMC8351262
http://europepmc.org/articles/PMC8351262
Autor:
Nadav Michaan, Dan Grisaru, Michael Lavie, Tamar Safra, Shira Peleg Hasson, Lyri Adar, Ido Laskov, Yael Raz, Eliya Shachar
Publikováno v:
Gynecologic Oncology. 162:S241-S242
Objectives: Although non-inferior overall survival and reduced surgical morbidity with neoadjuvant therapy (NAC) compared to primary debulking surgery, upfront debulking surgery remains the treatment of choice for newly diagnosed advanced stage ovari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::670b4c4e97f6516f39399dcd21b54bfc
https://doi.org/10.1016/s0090-8258(21)01110-0
https://doi.org/10.1016/s0090-8258(21)01110-0
Autor:
Miriam R. Brezis, T. Safra, Lee Galmor, Yuval Raviv, Shira Peleg Hasson, Lyri Adar, Dov Hershkovizh, Eliya Shachar
Publikováno v:
Journal of Clinical Oncology. 39:5553-5553
5553 Background: Ovarian cancer (OC) is the second most common gynecologic malignancy and the most common cause of gynecologic cancer mortality in the United States. Homologous recombination deficiency (HRD), including the BRCA mutations, are found i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::321a4ceec8d7bacb949daa39993cbeb0
https://doi.org/10.1200/jco.2021.39.15_suppl.5553
https://doi.org/10.1200/jco.2021.39.15_suppl.5553